Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis

Giovanni Caocci; Olga Mulas; Mario Annunziata; Luigiana Luciano; Massimiliano Bonifacio; Ester Maria Orlandi; Patrizia Pregno; Sara Galimberti; Antonella Russo Rossi; Elisabetta Abruzzese; Alessandra Iurlo; Bruno Martino; Nicola Sgherza; Gianni Binotto; Fausto Castagnetti; Antonella Gozzini; Claudio Fozza; Monica Bocchia; Anna Sicuranza; Fabio Stagno; Fabio Efficace; Emilio Usala; Fiorenza De Gregorio; Luigi Scaffidi; Chiara Elena; Francesca Pirillo; Claudia Baratè; Malgorzata Monika Trawinska; Daniele Cattaneo; Claudia Labate; Gabriele Gugliotta; Matteo Molica; Giorgina Specchia; Giorgio La Nasa; Robin Foà; Massimo Breccia

doi:10.1002/ajh.25102

Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis

Giovanni Caocci, Olga Mulas, Mario Annunziata, Luigiana Luciano, Massimiliano Bonifacio, Ester Maria Orlandi, Patrizia Pregno, Sara Galimberti, Antonella Russo Rossi, Elisabetta Abruzzese, Alessandra Iurlo, Bruno Martino, Nicola Sgherza, Gianni Binotto, Fausto Castagnetti, Antonella Gozzini, Claudio Fozza, Monica Bocchia, Anna Sicuranza, Fabio StagnoFabio Efficace, Emilio Usala, Fiorenza De Gregorio, Luigi Scaffidi, Chiara Elena, Francesca Pirillo, Claudia Baratè, Malgorzata Monika Trawinska, Daniele Cattaneo, Claudia Labate, Gabriele Gugliotta, Matteo Molica, Giorgina Specchia, Giorgio La Nasa, Robin Foà, Massimo Breccia

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	E159-E161
Journal	American Journal of Hematology
Volume	93
Issue number	7
DOIs	https://doi.org/10.1002/ajh.25102
Publication status	Published - Jul 2018

Access to Document

10.1002/ajh.25102

Cite this

Caocci, G., Mulas, O., Annunziata, M., Luciano, L., Bonifacio, M., Orlandi, E. M., Pregno, P., Galimberti, S., Russo Rossi, A., Abruzzese, E., Iurlo, A., Martino, B., Sgherza, N., Binotto, G., Castagnetti, F., Gozzini, A., Fozza, C., Bocchia, M., Sicuranza, A., ... Breccia, M. (2018). Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis. American Journal of Hematology, 93(7), E159-E161. https://doi.org/10.1002/ajh.25102

Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice : Identification of risk factors and the role of prophylaxis. / Caocci, Giovanni; Mulas, Olga; Annunziata, Mario; Luciano, Luigiana; Bonifacio, Massimiliano; Orlandi, Ester Maria; Pregno, Patrizia; Galimberti, Sara; Russo Rossi, Antonella; Abruzzese, Elisabetta; Iurlo, Alessandra; Martino, Bruno; Sgherza, Nicola; Binotto, Gianni; Castagnetti, Fausto; Gozzini, Antonella; Fozza, Claudio; Bocchia, Monica; Sicuranza, Anna; Stagno, Fabio; Efficace, Fabio; Usala, Emilio; De Gregorio, Fiorenza; Scaffidi, Luigi; Elena, Chiara; Pirillo, Francesca; Baratè, Claudia; Trawinska, Malgorzata Monika; Cattaneo, Daniele; Labate, Claudia; Gugliotta, Gabriele; Molica, Matteo; Specchia, Giorgina; La Nasa, Giorgio; Foà, Robin; Breccia, Massimo.

In: American Journal of Hematology, Vol. 93, No. 7, 07.2018, p. E159-E161.

Research output: Contribution to journal › Article › peer-review

Caocci, G, Mulas, O, Annunziata, M, Luciano, L, Bonifacio, M, Orlandi, EM, Pregno, P, Galimberti, S, Russo Rossi, A, Abruzzese, E, Iurlo, A, Martino, B, Sgherza, N, Binotto, G, Castagnetti, F, Gozzini, A, Fozza, C, Bocchia, M, Sicuranza, A, Stagno, F, Efficace, F, Usala, E, De Gregorio, F, Scaffidi, L, Elena, C, Pirillo, F, Baratè, C, Trawinska, MM, Cattaneo, D, Labate, C, Gugliotta, G, Molica, M, Specchia, G, La Nasa, G, Foà, R & Breccia, M 2018, 'Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis', American Journal of Hematology, vol. 93, no. 7, pp. E159-E161. https://doi.org/10.1002/ajh.25102

Caocci G, Mulas O, Annunziata M, Luciano L, Bonifacio M, Orlandi EM et al. Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis. American Journal of Hematology. 2018 Jul;93(7):E159-E161. https://doi.org/10.1002/ajh.25102

Caocci, Giovanni ; Mulas, Olga ; Annunziata, Mario ; Luciano, Luigiana ; Bonifacio, Massimiliano ; Orlandi, Ester Maria ; Pregno, Patrizia ; Galimberti, Sara ; Russo Rossi, Antonella ; Abruzzese, Elisabetta ; Iurlo, Alessandra ; Martino, Bruno ; Sgherza, Nicola ; Binotto, Gianni ; Castagnetti, Fausto ; Gozzini, Antonella ; Fozza, Claudio ; Bocchia, Monica ; Sicuranza, Anna ; Stagno, Fabio ; Efficace, Fabio ; Usala, Emilio ; De Gregorio, Fiorenza ; Scaffidi, Luigi ; Elena, Chiara ; Pirillo, Francesca ; Baratè, Claudia ; Trawinska, Malgorzata Monika ; Cattaneo, Daniele ; Labate, Claudia ; Gugliotta, Gabriele ; Molica, Matteo ; Specchia, Giorgina ; La Nasa, Giorgio ; Foà, Robin ; Breccia, Massimo. / Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice : Identification of risk factors and the role of prophylaxis. In: American Journal of Hematology. 2018 ; Vol. 93, No. 7. pp. E159-E161.

@article{93ee7a4a36f24bafbac5596b5f715d4f,

title = "Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis",

author = "Giovanni Caocci and Olga Mulas and Mario Annunziata and Luigiana Luciano and Massimiliano Bonifacio and Orlandi, {Ester Maria} and Patrizia Pregno and Sara Galimberti and {Russo Rossi}, Antonella and Elisabetta Abruzzese and Alessandra Iurlo and Bruno Martino and Nicola Sgherza and Gianni Binotto and Fausto Castagnetti and Antonella Gozzini and Claudio Fozza and Monica Bocchia and Anna Sicuranza and Fabio Stagno and Fabio Efficace and Emilio Usala and {De Gregorio}, Fiorenza and Luigi Scaffidi and Chiara Elena and Francesca Pirillo and Claudia Barat{\`e} and Trawinska, {Malgorzata Monika} and Daniele Cattaneo and Claudia Labate and Gabriele Gugliotta and Matteo Molica and Giorgina Specchia and {La Nasa}, Giorgio and Robin Fo{\`a} and Massimo Breccia",

year = "2018",

month = jul,

doi = "10.1002/ajh.25102",

language = "English",

volume = "93",

pages = "E159--E161",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

number = "7",

}

TY - JOUR

T1 - Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice

T2 - Identification of risk factors and the role of prophylaxis

AU - Caocci, Giovanni

AU - Mulas, Olga

AU - Annunziata, Mario

AU - Luciano, Luigiana

AU - Bonifacio, Massimiliano

AU - Orlandi, Ester Maria

AU - Pregno, Patrizia

AU - Galimberti, Sara

AU - Russo Rossi, Antonella

AU - Abruzzese, Elisabetta

AU - Iurlo, Alessandra

AU - Martino, Bruno

AU - Sgherza, Nicola

AU - Binotto, Gianni

AU - Castagnetti, Fausto

AU - Gozzini, Antonella

AU - Fozza, Claudio

AU - Bocchia, Monica

AU - Sicuranza, Anna

AU - Stagno, Fabio

AU - Efficace, Fabio

AU - Usala, Emilio

AU - De Gregorio, Fiorenza

AU - Scaffidi, Luigi

AU - Elena, Chiara

AU - Pirillo, Francesca

AU - Baratè, Claudia

AU - Trawinska, Malgorzata Monika

AU - Cattaneo, Daniele

AU - Labate, Claudia

AU - Gugliotta, Gabriele

AU - Molica, Matteo

AU - Specchia, Giorgina

AU - La Nasa, Giorgio

AU - Foà, Robin

AU - Breccia, Massimo

PY - 2018/7

Y1 - 2018/7

U2 - 10.1002/ajh.25102

DO - 10.1002/ajh.25102

M3 - Article

C2 - 29633312

VL - 93

SP - E159-E161

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 7

ER -